Schott Pharma is investing over €100 million to build a new sterile, ready-to-use (RTU) cartridge production facility at its site in Lukácsháza, Hungary. The expansion will support increased demand for drug delivery systems used in biologics, diabetes, and obesity treatments.

The facility will include fully automated production and sterilisation systems with an emphasis on environmental efficiency. This will be Schott’s second global RTU cartridge site, reinforcing its focus on high-value pharmaceutical packaging and expanding its supply chain capabilities in Europe.